Skip to main content
NCBI home page
Thorax logoLink to Thorax
. 2001 Jan;56(1):73–77. doi: 10.1136/thorax.56.1.73

Enhancing physical performance in chronic obstructive pulmonary disease

M Steiner 1, M Morgan 1
PMCID: PMC1745895  PMID: 11120909

Full Text

The Full Text of this article is available as a PDF (92.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Appell H. J. Muscular atrophy following immobilisation. A review. Sports Med. 1990 Jul;10(1):42–58. doi: 10.2165/00007256-199010010-00005. [DOI] [PubMed] [Google Scholar]
  2. Belman M. J., Kendregan B. A. Exercise training fails to increase skeletal muscle enzymes in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1981 Mar;123(3):256–261. doi: 10.1164/arrd.1981.123.3.256. [DOI] [PubMed] [Google Scholar]
  3. Bernard S., LeBlanc P., Whittom F., Carrier G., Jobin J., Belleau R., Maltais F. Peripheral muscle weakness in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998 Aug;158(2):629–634. doi: 10.1164/ajrccm.158.2.9711023. [DOI] [PubMed] [Google Scholar]
  4. Booth F. W., Gollnick P. D. Effects of disuse on the structure and function of skeletal muscle. Med Sci Sports Exerc. 1983;15(5):415–420. [PubMed] [Google Scholar]
  5. Burdet L., de Muralt B., Schutz Y., Pichard C., Fitting J. W. Administration of growth hormone to underweight patients with chronic obstructive pulmonary disease. A prospective, randomized, controlled study. Am J Respir Crit Care Med. 1997 Dec;156(6):1800–1806. doi: 10.1164/ajrccm.156.6.9704142. [DOI] [PubMed] [Google Scholar]
  6. Casaburi R., Patessio A., Ioli F., Zanaboni S., Donner C. F., Wasserman K. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. Am Rev Respir Dis. 1991 Jan;143(1):9–18. doi: 10.1164/ajrccm/143.1.9. [DOI] [PubMed] [Google Scholar]
  7. Casey A., Constantin-Teodosiu D., Howell S., Hultman E., Greenhaff P. L. Creatine ingestion favorably affects performance and muscle metabolism during maximal exercise in humans. Am J Physiol. 1996 Jul;271(1 Pt 1):E31–E37. doi: 10.1152/ajpendo.1996.271.1.E31. [DOI] [PubMed] [Google Scholar]
  8. Clark C. J., Cochrane L., Mackay E. Low intensity peripheral muscle conditioning improves exercise tolerance and breathlessness in COPD. Eur Respir J. 1996 Dec;9(12):2590–2596. doi: 10.1183/09031936.96.09122590. [DOI] [PubMed] [Google Scholar]
  9. Constantin-Teodosiu D., Greenhaff P. L., McIntyre D. B., Round J. M., Jones D. A. Anaerobic energy production in human skeletal muscle in intense contraction: a comparison of 31P magnetic resonance spectroscopy and biochemical techniques. Exp Physiol. 1997 May;82(3):593–601. doi: 10.1113/expphysiol.1997.sp004049. [DOI] [PubMed] [Google Scholar]
  10. Coyle E. F., Coggan A. R., Hemmert M. K., Ivy J. L. Muscle glycogen utilization during prolonged strenuous exercise when fed carbohydrate. J Appl Physiol (1985) 1986 Jul;61(1):165–172. doi: 10.1152/jappl.1986.61.1.165. [DOI] [PubMed] [Google Scholar]
  11. Decramer M., Lacquet L. M., Fagard R., Rogiers P. Corticosteroids contribute to muscle weakness in chronic airflow obstruction. Am J Respir Crit Care Med. 1994 Jul;150(1):11–16. doi: 10.1164/ajrccm.150.1.8025735. [DOI] [PubMed] [Google Scholar]
  12. Efthimiou J., Mounsey P. J., Benson D. N., Madgwick R., Coles S. J., Benson M. K. Effect of carbohydrate rich versus fat rich loads on gas exchange and walking performance in patients with chronic obstructive lung disease. Thorax. 1992 Jun;47(6):451–456. doi: 10.1136/thx.47.6.451. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Engelen M. P., Schols A. M., Baken W. C., Wesseling G. J., Wouters E. F. Nutritional depletion in relation to respiratory and peripheral skeletal muscle function in out-patients with COPD. Eur Respir J. 1994 Oct;7(10):1793–1797. doi: 10.1183/09031936.94.07101793. [DOI] [PubMed] [Google Scholar]
  14. Ferreira I. M., Brooks D., Lacasse Y., Goldstein R. S. Nutritional support for individuals with COPD: a meta-analysis. Chest. 2000 Mar;117(3):672–678. doi: 10.1378/chest.117.3.672. [DOI] [PubMed] [Google Scholar]
  15. Fiaccadori E., Del Canale S., Vitali P., Coffrini E., Ronda N., Guariglia A. Skeletal muscle energetics, acid-base equilibrium and lactate metabolism in patients with severe hypercapnia and hypoxemia. Chest. 1987 Nov;92(5):883–887. doi: 10.1378/chest.92.5.883. [DOI] [PubMed] [Google Scholar]
  16. Fiatarone M. A., O'Neill E. F., Ryan N. D., Clements K. M., Solares G. R., Nelson M. E., Roberts S. B., Kehayias J. J., Lipsitz L. A., Evans W. J. Exercise training and nutritional supplementation for physical frailty in very elderly people. N Engl J Med. 1994 Jun 23;330(25):1769–1775. doi: 10.1056/NEJM199406233302501. [DOI] [PubMed] [Google Scholar]
  17. Fulco C. S., Rock P. B., Cymerman A. Improving athletic performance: is altitude residence or altitude training helpful? Aviat Space Environ Med. 2000 Feb;71(2):162–171. [PubMed] [Google Scholar]
  18. Garrod R., Paul E. A., Wedzicha J. A. Supplemental oxygen during pulmonary rehabilitation in patients with COPD with exercise hypoxaemia. Thorax. 2000 Jul;55(7):539–543. doi: 10.1136/thorax.55.7.539. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Goldstein R. S., Gort E. H., Stubbing D., Avendano M. A., Guyatt G. H. Randomised controlled trial of respiratory rehabilitation. Lancet. 1994 Nov 19;344(8934):1394–1397. doi: 10.1016/s0140-6736(94)90568-1. [DOI] [PubMed] [Google Scholar]
  20. Gosselink R., Decramer M. Peripheral skeletal muscles and exercise performance in patients with chronic obstructive pulmonary disease. Monaldi Arch Chest Dis. 1998 Aug;53(4):419–423. [PubMed] [Google Scholar]
  21. Gosselink R., Troosters T., Decramer M. Peripheral muscle weakness contributes to exercise limitation in COPD. Am J Respir Crit Care Med. 1996 Mar;153(3):976–980. doi: 10.1164/ajrccm.153.3.8630582. [DOI] [PubMed] [Google Scholar]
  22. Greenhaff P. L., Timmons J. A. Interaction between aerobic and anaerobic metabolism during intense muscle contraction. Exerc Sport Sci Rev. 1998;26:1–30. [PubMed] [Google Scholar]
  23. Griffiths T. L., Burr M. L., Campbell I. A., Lewis-Jenkins V., Mullins J., Shiels K., Turner-Lawlor P. J., Payne N., Newcombe R. G., Ionescu A. A. Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet. 2000 Jan 29;355(9201):362–368. doi: 10.1016/s0140-6736(99)07042-7. [DOI] [PubMed] [Google Scholar]
  24. Heigenhauser G. J., Parolin M. L. Role of pyruvate dehydrogenase in lactate production in exercising human skeletal muscle. Adv Exp Med Biol. 1999;474:205–218. doi: 10.1007/978-1-4615-4711-2_17. [DOI] [PubMed] [Google Scholar]
  25. Honeyman P., Barr P., Stubbing D. G. Effect of a walking aid on disability, oxygenation, and breathlessness in patients with chronic airflow limitation. J Cardiopulm Rehabil. 1996 Jan-Feb;16(1):63–67. doi: 10.1097/00008483-199601000-00008. [DOI] [PubMed] [Google Scholar]
  26. Keilty S. E., Ponte J., Fleming T. A., Moxham J. Effect of inspiratory pressure support on exercise tolerance and breathlessness in patients with severe stable chronic obstructive pulmonary disease. Thorax. 1994 Oct;49(10):990–994. doi: 10.1136/thx.49.10.990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Killian K. J., Leblanc P., Martin D. H., Summers E., Jones N. L., Campbell E. J. Exercise capacity and ventilatory, circulatory, and symptom limitation in patients with chronic airflow limitation. Am Rev Respir Dis. 1992 Oct;146(4):935–940. doi: 10.1164/ajrccm/146.4.935. [DOI] [PubMed] [Google Scholar]
  28. Kutsuzawa T., Shioya S., Kurita D., Haida M., Ohta Y., Yamabayashi H. Muscle energy metabolism and nutritional status in patients with chronic obstructive pulmonary disease. A 31P magnetic resonance study. Am J Respir Crit Care Med. 1995 Aug;152(2):647–652. doi: 10.1164/ajrccm.152.2.7633721. [DOI] [PubMed] [Google Scholar]
  29. Lacasse Y., Wong E., Guyatt G. H., King D., Cook D. J., Goldstein R. S. Meta-analysis of respiratory rehabilitation in chronic obstructive pulmonary disease. Lancet. 1996 Oct 26;348(9035):1115–1119. doi: 10.1016/S0140-6736(96)04201-8. [DOI] [PubMed] [Google Scholar]
  30. Leach R. M., Davidson A. C., Chinn S., Twort C. H., Cameron I. R., Bateman N. T. Portable liquid oxygen and exercise ability in severe respiratory disability. Thorax. 1992 Oct;47(10):781–789. doi: 10.1136/thx.47.10.781. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Leggett R. J., Flenley D. C. Portable oxygen and exercise tolerance in patients with chronic hypoxic cor pulmonale. Br Med J. 1977 Jul 9;2(6079):84–86. doi: 10.1136/bmj.2.6079.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Levine B. D., Stray-Gundersen J. "Living high-training low": effect of moderate-altitude acclimatization with low-altitude training on performance. J Appl Physiol (1985) 1997 Jul;83(1):102–112. doi: 10.1152/jappl.1997.83.1.102. [DOI] [PubMed] [Google Scholar]
  33. Levy R. D., Ernst P., Levine S. M., Shennib H., Anzueto A., Bryan C. L., Calhoon J. H., Trinkle J. K., Jenkinson S. G., Gibbons W. J. Exercise performance after lung transplantation. J Heart Lung Transplant. 1993 Jan-Feb;12(1 Pt 1):27–33. [PubMed] [Google Scholar]
  34. Low D. E., Trulock E. P., Kaiser L. R., Pasque M. K., Dresler C., Ettinger N., Cooper J. D. Morbidity, mortality, and early results of single versus bilateral lung transplantation for emphysema. J Thorac Cardiovasc Surg. 1992 Jun;103(6):1119–1126. [PubMed] [Google Scholar]
  35. Ludvik B., Mayer G., Stifter S., Putz D., Barnas U., Graf H. Effects of dichloroacetate on exercise performance in healthy volunteers. Pflugers Arch. 1993 May;423(3-4):251–254. doi: 10.1007/BF00374403. [DOI] [PubMed] [Google Scholar]
  36. Mahler M. First-order kinetics of muscle oxygen consumption, and an equivalent proportionality between QO2 and phosphorylcreatine level. Implications for the control of respiration. J Gen Physiol. 1985 Jul;86(1):135–165. doi: 10.1085/jgp.86.1.135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Maltais F., Jobin J., Sullivan M. J., Bernard S., Whittom F., Killian K. J., Desmeules M., Bélanger M., LeBlanc P. Metabolic and hemodynamic responses of lower limb during exercise in patients with COPD. J Appl Physiol (1985) 1998 May;84(5):1573–1580. doi: 10.1152/jappl.1998.84.5.1573. [DOI] [PubMed] [Google Scholar]
  38. Maltais F., LeBlanc P., Simard C., Jobin J., Bérubé C., Bruneau J., Carrier L., Belleau R. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996 Aug;154(2 Pt 1):442–447. doi: 10.1164/ajrccm.154.2.8756820. [DOI] [PubMed] [Google Scholar]
  39. Maltais F., Simard A. A., Simard C., Jobin J., Desgagnés P., LeBlanc P. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. Am J Respir Crit Care Med. 1996 Jan;153(1):288–293. doi: 10.1164/ajrccm.153.1.8542131. [DOI] [PubMed] [Google Scholar]
  40. Mannix E. T., Boska M. D., Galassetti P., Burton G., Manfredi F., Farber M. O. Modulation of ATP production by oxygen in obstructive lung disease as assessed by 31P-MRS. J Appl Physiol (1985) 1995 Jun;78(6):2218–2227. doi: 10.1152/jappl.1995.78.6.2218. [DOI] [PubMed] [Google Scholar]
  41. Martineau L., Horan M. A., Rothwell N. J., Little R. A. Salbutamol, a beta 2-adrenoceptor agonist, increases skeletal muscle strength in young men. Clin Sci (Lond) 1992 Nov;83(5):615–621. doi: 10.1042/cs0830615. [DOI] [PubMed] [Google Scholar]
  42. McCully K., Mancini D., Levine S. Nuclear magnetic resonance spectroscopy: its role in providing valuable insight into diverse clinical problems. Chest. 1999 Nov;116(5):1434–1441. doi: 10.1378/chest.116.5.1434. [DOI] [PubMed] [Google Scholar]
  43. Meeuwisse W. H., McKenzie D. C., Hopkins S. R., Road J. D. The effect of salbutamol on performance in elite nonasthmatic athletes. Med Sci Sports Exerc. 1992 Oct;24(10):1161–1166. [PubMed] [Google Scholar]
  44. Morgan A. D., Peck D. F., Buchanan D. R., McHardy G. J. Effect of attitudes and beliefs on exercise tolerance in chronic bronchitis. Br Med J (Clin Res Ed) 1983 Jan 15;286(6360):171–173. doi: 10.1136/bmj.286.6360.171. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. O'Donnell D. E., Bain D. J., Webb K. A. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med. 1997 Feb;155(2):530–535. doi: 10.1164/ajrccm.155.2.9032190. [DOI] [PubMed] [Google Scholar]
  46. Pape G. S., Friedman M., Underwood L. E., Clemmons D. R. The effect of growth hormone on weight gain and pulmonary function in patients with chronic obstructive lung disease. Chest. 1991 Jun;99(6):1495–1500. doi: 10.1378/chest.99.6.1495. [DOI] [PubMed] [Google Scholar]
  47. Payen J. F., Wuyam B., Levy P., Reutenauer H., Stieglitz P., Paramelle B., Le Bas J. F. Muscular metabolism during oxygen supplementation in patients with chronic hypoxemia. Am Rev Respir Dis. 1993 Mar;147(3):592–598. doi: 10.1164/ajrccm/147.3.592. [DOI] [PubMed] [Google Scholar]
  48. Polkey M. I., Hawkins P., Kyroussis D., Ellum S. G., Sherwood R., Moxham J. Inspiratory pressure support prolongs exercise induced lactataemia in severe COPD. Thorax. 2000 Jul;55(7):547–549. doi: 10.1136/thorax.55.7.547. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Putman C. T., Spriet L. L., Hultman E., Dyck D. J., Heigenhauser G. J. Skeletal muscle pyruvate dehydrogenase activity during acetate infusion in humans. Am J Physiol. 1995 May;268(5 Pt 1):E1007–E1017. doi: 10.1152/ajpendo.1995.268.5.E1007. [DOI] [PubMed] [Google Scholar]
  50. Revill S. M., Morgan M. D. The cardiorespiratory response to submaximal exercise in subjects with asthma following pretreatment with controlled release oral salbutamol and high-dose inhaled salmeterol. Respir Med. 1998 Aug;92(8):1053–1058. doi: 10.1016/s0954-6111(98)90354-7. [DOI] [PubMed] [Google Scholar]
  51. Roomi J., Yohannes A. M., Connolly M. J. The effect of walking aids on exercise capacity and oxygenation in elderly patients with chronic obstructive pulmonary disease. Age Ageing. 1998 Nov;27(6):703–706. doi: 10.1093/ageing/27.6.703. [DOI] [PubMed] [Google Scholar]
  52. Rooyackers J. M., Dekhuijzen P. N., Van Herwaarden C. L., Folgering H. T. Training with supplemental oxygen in patients with COPD and hypoxaemia at peak exercise. Eur Respir J. 1997 Jun;10(6):1278–1284. doi: 10.1183/09031936.97.10061278. [DOI] [PubMed] [Google Scholar]
  53. Sala E., Roca J., Marrades R. M., Alonso J., Gonzalez De Suso J. M., Moreno A., Barberá J. A., Nadal J., de Jover L., Rodriguez-Roisin R. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999 Jun;159(6):1726–1734. doi: 10.1164/ajrccm.159.6.9804136. [DOI] [PubMed] [Google Scholar]
  54. Schols A. M., Soeters P. B., Dingemans A. M., Mostert R., Frantzen P. J., Wouters E. F. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993 May;147(5):1151–1156. doi: 10.1164/ajrccm/147.5.1151. [DOI] [PubMed] [Google Scholar]
  55. Schols A. M., Soeters P. B., Mostert R., Pluymers R. J., Wouters E. F. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med. 1995 Oct;152(4 Pt 1):1268–1274. doi: 10.1164/ajrccm.152.4.7551381. [DOI] [PubMed] [Google Scholar]
  56. Schols A. M., Wouters E. F., Soeters P. B., Westerterp K. R. Body composition by bioelectrical-impedance analysis compared with deuterium dilution and skinfold anthropometry in patients with chronic obstructive pulmonary disease. Am J Clin Nutr. 1991 Feb;53(2):421–424. doi: 10.1093/ajcn/53.2.421. [DOI] [PubMed] [Google Scholar]
  57. Stacpoole P. W. The pharmacology of dichloroacetate. Metabolism. 1989 Nov;38(11):1124–1144. doi: 10.1016/0026-0495(89)90051-6. [DOI] [PubMed] [Google Scholar]
  58. Sue D. Y., Wasserman K., Moricca R. B., Casaburi R. Metabolic acidosis during exercise in patients with chronic obstructive pulmonary disease. Use of the V-slope method for anaerobic threshold determination. Chest. 1988 Nov;94(5):931–938. doi: 10.1378/chest.94.5.931. [DOI] [PubMed] [Google Scholar]
  59. Terjung R. L., Clarkson P., Eichner E. R., Greenhaff P. L., Hespel P. J., Israel R. G., Kraemer W. J., Meyer R. A., Spriet L. L., Tarnopolsky M. A. American College of Sports Medicine roundtable. The physiological and health effects of oral creatine supplementation. Med Sci Sports Exerc. 2000 Mar;32(3):706–717. doi: 10.1097/00005768-200003000-00024. [DOI] [PubMed] [Google Scholar]
  60. Whittom F., Jobin J., Simard P. M., Leblanc P., Simard C., Bernard S., Belleau R., Maltais F. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. Med Sci Sports Exerc. 1998 Oct;30(10):1467–1474. doi: 10.1097/00005768-199810000-00001. [DOI] [PubMed] [Google Scholar]
  61. Williams C. Macronutrients and performance. J Sports Sci. 1995 Summer;13(Spec No):S1–10. doi: 10.1080/02640419508732271. [DOI] [PubMed] [Google Scholar]
  62. Wilson D. O., Rogers R. M., Wright E. C., Anthonisen N. R. Body weight in chronic obstructive pulmonary disease. The National Institutes of Health Intermittent Positive-Pressure Breathing Trial. Am Rev Respir Dis. 1989 Jun;139(6):1435–1438. doi: 10.1164/ajrccm/139.6.1435. [DOI] [PubMed] [Google Scholar]
  63. Yang Y. T., McElligott M. A. Multiple actions of beta-adrenergic agonists on skeletal muscle and adipose tissue. Biochem J. 1989 Jul 1;261(1):1–10. doi: 10.1042/bj2610001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Yohannes A. M., Roomi J., Connolly M. J. Elderly people at home disabled by chronic obstructive pulmonary disease. Age Ageing. 1998 Jul;27(4):523–525. doi: 10.1093/ageing/27.4.523. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES